The FDA just approved Viramune (nevirapine)

July 1996

The FDA just approved Viramune (nevirapine)...the FIFTH new antiviral for HIV in just the last 6 months.

Viramune is the first drug in a new class called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It inhibits the same enzyme as AZT...but it works in a different way.

Experts don't yet know exactly how to use this drug.

Upgrade now for access to this resource

This content is not available under the subscriptions purchased by your organization, but you can add it on!

Prescriber Insights: APRN includes

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations